ÂÜÀòÂÒÂ×

Dr. Carter, Chief Scientific Officer, joined FibroGen in September of 2020. Dr. Carter oversees FibroGen’s scientific and preclinical efforts. He brings more than 20 years of global biopharmaceutical leadership and experience, with deep expertise in drug discovery.

Prior to joining FibroGen, Percy served as Global Head of Discovery Sciences at Janssen, worked in collaboration with therapeutic area discovery scientists and other stakeholders to define and operationalize innovative strategies for the successful identification and optimization of novel small molecule, peptide, and RNA-based drug candidates. Prior to his role with Janssen, Percy was Senior Vice President and Head of Discovery for Bristol-Myers Squibb (BMS).

Prior to that, he was Senior Vice President and Head of Discovery Chemistry & Molecular Technologies and was Site Lead for the Biocon-BMS R&D Center in Bangalore, India. Percy began his career as a Senior Research Scientist in Chemical and Physical Sciences at DuPont Pharmaceuticals. Dr. Carter received his bachelor’s degree in Organic Chemistry from Dartmouth College, his Ph.D. in Chemistry & Chemical Biology from Harvard University, and completed a post-doctoral fellowship at Harvard Medical School and Massachusetts General Hospital. In 2014, he received his M.B.A. from the Massachusetts Institute of Technology.